Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 26;13(4):e0196334.
doi: 10.1371/journal.pone.0196334. eCollection 2018.

Massively parallel sequencing of micro-manipulated cells targeting a comprehensive panel of disease-causing genes: A comparative evaluation of upstream whole-genome amplification methods

Affiliations

Massively parallel sequencing of micro-manipulated cells targeting a comprehensive panel of disease-causing genes: A comparative evaluation of upstream whole-genome amplification methods

Lieselot Deleye et al. PLoS One. .

Abstract

Single Gene Disorders (SGD) are still routinely diagnosed using PCR-based assays that need to be developed and validated for each individual disease-specific gene fragment. The TruSight One sequencing panel currently covers 12 Mb of genomic content, including 4813 genes associated with a clinical phenotype. When only a limited number of cells are available, whole genome amplification (WGA) is required prior to DNA target capture techniques such as the TruSight One panel. In this study, we compared 4 different WGA methods in combination with the TruSight One sequencing panel to perform single nucleotide polymorphism (SNP) genotyping starting from 3 micro-manipulated cells. This setting simulates clinical settings such as day-5 blastocyst biopsy for Preimplantation Genetic Testing (PGT), liquid biopsy of circulating tumor cells (CTCs) and cancer-cell profiling. Bulk cell samples were processed alongside these WGA samples to serve as a performance reference. Target coverage, coverage uniformity and SNP calling accuracy obtained using any of the WGA, is inferior to the results obtained on bulk cell samples. However, results after REPLI-g come close. Compared to the other WGA methods, the method using REPLI-g WGA results in a better coverage of the targeted genomic regions with a more uniform read depth. Consequently, this method also results in a more accurate SNP calling and could be considered for clinical genotyping of a limited number of cells.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Experimental design.
Three cell samples from the NA12882 cell line were amplified with either Ampli1 (3 replicates), REPLI-g (3 replicates), SurePlex (5 replicates) or MALBAC (3 replicates). Subsequently, samples were randomized for TruSight One capture in pools of 3 and those pools were sequenced on separate MiSeq runs. Four bulk DNA sample from the NA12882 cell line, not amplified before capture, were also randomly included in the pools.
Fig 2
Fig 2. Read distribution.
(A) Read depth calculated in 1 kb sliding windows across the concatenated target regions for one sample of each method. (B, C) Lorenz curves and Gini indexes describing how sequenced bases are distributed over targeted (B) and covered (C) bases.
Fig 3
Fig 3. Percent target coverage at various minimum read depths.

Similar articles

Cited by

References

    1. Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The International Glossary on Infertility and Fertility Care, 2017†‡§. Hum Reprod. 2017. September 1;32(9):1786–801. doi: 10.1093/humrep/dex234 - DOI - PMC - PubMed
    1. Deleye L, Dheedene A, De Coninck D, Sante T, Christodoulou C, Heindryckx B, et al. Shallow whole genome sequencing is well suited for the detection of chromosomal aberrations in human blastocysts. Fertil Steril. 2015. November 1;104(5):1276–1285.e1. doi: 10.1016/j.fertnstert.2015.07.1144 - DOI - PubMed
    1. Fiorentino F, Biricik A, Bono S, Spizzichino L, Cotroneo E, Cottone G, et al. Development and validation of a next-generation sequencing-based protocol for 24-chromosome aneuploidy screening of embryos. Fertil Steril. 2014. May 1;101(5):1375–1382.e2. doi: 10.1016/j.fertnstert.2014.01.051 - DOI - PubMed
    1. Wells D, Kaur K, Grifo J, Glassner M, Taylor JC, Fragouli E, et al. Clinical utilisation of a rapid low-pass whole genome sequencing technique for the diagnosis of aneuploidy in human embryos prior to implantation. J Med Genet. 2014. August 1;51(8):553–62. doi: 10.1136/jmedgenet-2014-102497 - DOI - PMC - PubMed
    1. Dreesen J, Destouni A, Kourlaba G, Degn B, Mette WC, Carvalho F, et al. Evaluation of PCR-based preimplantation genetic diagnosis applied to monogenic diseases: A collaborative ESHRE PGD consortium study. Eur J Hum Genet. 2014. August 4;22(8):1012–8. doi: 10.1038/ejhg.2013.277 - DOI - PMC - PubMed

Publication types

LinkOut - more resources